151 related articles for article (PubMed ID: 36920323)
1. A score for predicting invasive pulmonary aspergillosis in immunocompetent critically ill patients.
Li W; Chen G; Lin F; Yang H; Cui Y; Lu R; Song C; Li H; Li Y; Pan P
Eur J Clin Invest; 2023 Jul; 53(7):e13985. PubMed ID: 36920323
[TBL] [Abstract][Full Text] [Related]
2. Role of galactomannan determinations in bronchoalveolar lavage fluid samples from critically ill patients with chronic obstructive pulmonary disease for the diagnosis of invasive pulmonary aspergillosis: a prospective study.
He H; Ding L; Sun B; Li F; Zhan Q
Crit Care; 2012 Jul; 16(4):R138. PubMed ID: 22835335
[TBL] [Abstract][Full Text] [Related]
3. Comparison of 1,3-β-d-glucan with galactomannan in serum and bronchoalveolar fluid for the detection of Aspergillus species in immunosuppressed mechanical ventilated critically ill patients.
Lahmer T; Neuenhahn M; Held J; Rasch S; Schmid RM; Huber W
J Crit Care; 2016 Dec; 36():259-264. PubMed ID: 27475024
[TBL] [Abstract][Full Text] [Related]
4. CD8⁺ T-cell counts: an early predictor of risk and mortality in critically ill immunocompromised patients with invasive pulmonary aspergillosis.
Cui N; Wang H; Long Y; Liu D
Crit Care; 2013 Jul; 17(4):R157. PubMed ID: 23883548
[TBL] [Abstract][Full Text] [Related]
5. Putative invasive pulmonary aspergillosis in critically ill patients with chronic obstructive pulmonary disease: a matched cohort study.
Delsuc C; Cottereau A; Frealle E; Bienvenu AL; Dessein R; Jarraud S; Dumitrescu O; Le Maréchal M; Wallet F; Friggeri A; Argaud L; Rimmelé T; Nseir S; Ader F
Crit Care; 2015 Dec; 19():421. PubMed ID: 26631029
[TBL] [Abstract][Full Text] [Related]
6. A scoring system based on novel biomarkers and clinical risk factors to predict invasive candidiasis in immunocompetent critically ill patients.
Li W; Chen G; Lin F; Yang H; Cui Y; Lu R; Song C; Li H; Li Y; Pan P
Front Microbiol; 2023; 14():1097574. PubMed ID: 36970699
[TBL] [Abstract][Full Text] [Related]
7. Is Bulpa criteria suitable for the diagnosis of probable invasive pulmonary Aspergillosis in critically ill patients with chronic obstructive pulmonary disease? A comparative study with EORTC/ MSG and ICU criteria.
Huang L; He H; Jin J; Zhan Q
BMC Infect Dis; 2017 Mar; 17(1):209. PubMed ID: 28292284
[TBL] [Abstract][Full Text] [Related]
8. Value of consecutive galactomannan determinations for the diagnosis and prognosis of invasive pulmonary aspergillosis in critically ill chronic obstructive pulmonary disease.
He H; Ding L; Chang S; Li F; Zhan Q
Med Mycol; 2011 May; 49(4):345-51. PubMed ID: 20936913
[TBL] [Abstract][Full Text] [Related]
9. Significance of Aspergillus spp. isolation from lower respiratory tract samples for the diagnosis and prognosis of invasive pulmonary aspergillosis in chronic obstructive pulmonary disease.
He HY; Chang S; Ding L; Sun B; Li F; Zhan QY
Chin Med J (Engl); 2012 Sep; 125(17):2973-8. PubMed ID: 22932166
[TBL] [Abstract][Full Text] [Related]
10. [The diagnostic performance of galactomannan detection in invasive pulmonary aspergillosis with severe and critically ill influenza].
Lin PC; Zeng JH; Su SS; Zhou Y; Chen JJ; Chen CS; Li YP
Zhonghua Yi Xue Za Zhi; 2021 Apr; 101(15):1050-1056. PubMed ID: 33878831
[No Abstract] [Full Text] [Related]
11. Prognostic value of serum galactomannan index in critically ill patients with chronic obstructive pulmonary disease at risk of invasive pulmonary aspergillosis.
He H; Li Q; Chang S; Ding L; Sun B; Li F; Zhan Q
Chin Med J (Engl); 2014; 127(1):23-8. PubMed ID: 24384419
[TBL] [Abstract][Full Text] [Related]
12. Characteristics and outcomes for pulmonary aspergillosis in critically ill patients without influenza: A 3-year retrospective study.
Chao CM; Lai CC; Chan KS; Yang CC; Chen CM; Ho CH; Ou HF; Yu WL
J Infect Public Health; 2023 Dec; 16(12):2001-2009. PubMed ID: 37890223
[TBL] [Abstract][Full Text] [Related]
13. Usefulness of ICU criteria for diagnosis of invasive pulmonary aspergillosis in nonhematologic critically ill patients.
Lee SI; Sung H; Hong SB; Lim CM; Koh Y; Huh JW
Med Mycol; 2020 Apr; 58(3):275-281. PubMed ID: 31204780
[TBL] [Abstract][Full Text] [Related]
14. [Evaluation of risk factors for invasive pulmonary aspergillosis and detection of diagnostic values of galactomannan and PCR methods in bronchoalveolar lavage samples from non-neutropenic intensive care unit patients].
Özger S; Hızel K; Kalkancı A; Aydoğdu M; Civil F; Dizbay M; Gürsel G
Mikrobiyol Bul; 2015 Oct; 49(4):565-75. PubMed ID: 26649414
[TBL] [Abstract][Full Text] [Related]
15. Isolation of Aspergillus in critically ill patients: a potential marker of poor outcome.
Khasawneh F; Mohamad T; Moughrabieh MK; Lai Z; Ager J; Soubani AO
J Crit Care; 2006 Dec; 21(4):322-7. PubMed ID: 17175418
[TBL] [Abstract][Full Text] [Related]
16. Invasive pulmonary aspergillosis in the intensive care unit: current challenges and best practices.
Gaffney S; Kelly DM; Rameli PM; Kelleher E; Martin-Loeches I
APMIS; 2023 Nov; 131(11):654-667. PubMed ID: 37022291
[TBL] [Abstract][Full Text] [Related]
17. Invasive pulmonary aspergillosis in COVID-19 critically ill patients: Results of a French monocentric cohort.
Versyck M; Zarrougui W; Lambiotte F; Elbeki N; Saint-Leger P
J Mycol Med; 2021 Jun; 31(2):101122. PubMed ID: 33621792
[TBL] [Abstract][Full Text] [Related]
18. Approach to invasive pulmonary aspergillosis in critically ill patients.
Koulenti D; Garnacho-Montero J; Blot S
Curr Opin Infect Dis; 2014 Apr; 27(2):174-83. PubMed ID: 24514164
[TBL] [Abstract][Full Text] [Related]
19. A risk-predictive model for invasive pulmonary aspergillosis in patients with acute exacerbation of chronic obstructive pulmonary disease.
Gu Y; Ye X; Liu Y; Wang Y; Shen K; Zhong J; Chen B; Su X
Respir Res; 2021 Jun; 22(1):176. PubMed ID: 34107968
[TBL] [Abstract][Full Text] [Related]
20. Invasive Tracheobronchial Aspergillosis in Critically Ill Patients with Severe Influenza. A Clinical Trial.
Nyga R; Maizel J; Nseir S; Chouaki T; Milic I; Roger PA; Van Grunderbeeck N; Lemyze M; Totet A; Castelain S; Slama M; Dupont H; Sendid B; Zogheib E
Am J Respir Crit Care Med; 2020 Sep; 202(5):708-716. PubMed ID: 32407157
[No Abstract] [Full Text] [Related]
[Next] [New Search]
